Global Medical Active Air Sampling System Market - 2022-2029

Global Medical Active Air Sampling System Market - 2022-2029

Market Overview

Medical Active Air Sampling System Market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of x% during the forecast period (2022-2029).

The medical active air sampling system is an effective monitoring system that ensures key areas such as pharmaceutical production areas, medical facilities, and food manufacturing meet the demand for microbial limits.

Market Dynamics

The medical active air sampling system market growth is driven by the increasing regulation in pharmaceutical and medical device manufacturing operations for product and patient safety, rising use in food manufacturing areas and research activities.

The rising regulations of microbiological monitoring are expected to drive the market’s growth

The rising regulations for microbiological monitoring are expected to boost the market over the forecast period. Air sampling is essential for quality control (QC) in biotechnology, healthcare laboratories, and the pharmaceutical sector. Various regulatory authorities, such as the Occupational Safety and Health Administration (OSHA) in the United States and the Health and Safety Executive (HSE) in the United Kingdom, have created strict regulations to limit the exposure of bacteria and viruses in the air. Yeasts, airborne bacteria and moulds impact on pharmaceutical and medical device operations activities, which is a real threat to product and patient safety. In the pharmaceticals and medical device areas, microbiological monitoring is essential. Furthermore, in developed countries such as the United States and the United Kingdom, it is a regulatory requirements, and international standards are already published for biocontamination control in cleanrooms and other controlled areas (ISO 14698-1/2). Also, airborne bacteria and fungi are contributory factors to sick building syndrome. Therefore, monitoring airborne microorganisms is a key factor in many sectors. In addition, many pharmacisits and health care practitioners achieved an effective monitoring programme to develop a variety of technological solutions in the pharmaceutical sector and hospitals to provide good treatment to patients.

Furthermore, the significant rising level of pollution leads to the spread of diseases such as asthma, cardio-vascular disease, and obstructive pulmonary disease in people. The increase in awareness of the side effects of polluted air drives the market growth worldwide.

The high cost of medical active air sampling system will hamper the growth of the market

However, the lack of regulations in developing countries and the high cost of sampliing systems restrain the market's growth. Additionally, many samplers are subject to the effects of temperature, sampling duration, and air conditioning. It varies from system to system. It may have a negative impact on the medical active air sampling systems market.

COVID-19 Impact Analysis

The appearance of COVID-19 positively impacted the global medical active air sampling system market. The demand for medical active air sampling systems varies from region to region, primarily becaus use of air samplers is increased in COVID-19 due to the need to keep cleanliness in the hospital to maintain patient health. According to the World Health Organization (WHO), nearly 50 million COVID-19 (SARS-COV-2) confirmed cases were reported in 2020. SARS-CoV-2 genomic RNA was detected in airborne material collected by air samplers from COVID-19 patients from a distance. It has a useful role in the etiologic agents of many bacterial respiratory infections. As the COVID-19 pandemic rises, technological applications and initiatives are developed by market players or research institutes to control the spread of the disease. For instance, the National Institute for Occupational Safety and Health (NIOSH) introduced the Anderson bioaerosol sampler for sampling and identification of culturable microorganisms in workplaces. Different types of sampler devices can be used to maintain air quality, particularly liquid and solid impactors for indoor air sampling during COVID-19. Furthermore, key players are launching new products into the market. For instance, in February 2020, Pharmagraph introduced its new range of smart active air samplers named the iVAS Series, which offers high efficiency and consistency in microbiological monitoring.

Segment Analysis

The portable microbial sampling system is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The portable microbial sampling systems segment is expected to boost the market over the period of the forecast. This is owing to the increased use of portable microbial sampling systems in pharmaceutical and biotechnology companies to maintain air quality. These portable or mobile air samplers are used for quantitative determination of airborne contamination in cleanrooms and isolators to maintain cleanliness. These mobile samplers can be moved or used in various environments with different levels of microbial contamination. These samplers are easy to use, lightweight and reliable for environmental monitoring applications in pharmaceutical cleanrooms, in operation theaters, cosmetic manufacturers, medical device and healthcare facilities, and food manufacturing. Reliable compliance is provided with the mobile samplers with USP 797 & 1116 regulations, and DQ, IQ, and OQ documentation are supplied with the device. Moreover, systems such as P100 portable air samplers allow users to create and store specific sampling plans, including Delay/Test/Hold functionality, while handling the sample site description and maintenance. In addition, the VWR offers SAS Super ISO 100 and SAS Super ISO 180, which provide continuous and sequetial air flow from a few minutes to several hours and can be used for a variety of applications in hospitals or laboratories. The SAS Super ISO is specifically designed for the pharmaceutical and hospital sectors.

Geographical Analysis

North America region holds the largest market share of the global medical active air sampling system market

North America dominates the market for medical active air sampling system and is expected to show a similar trend over the forecast period (2022-2029). The drivers of the market in the region include the high adoption of medical active air sampling systems among health care practitioners and pharmacists for research activities. The increasing healthcare infrastructure, increasing research activities and technological advancements drive the medical active air sampling system market in the region. For instance, in September 2021, the Occupational Safety and Health Administration (OSHA) in the United States published standard guidelines for indoor air quality. The OSHA guidelines (which include temperature controls, poor ventilation, and others) are applied to business operations to regulate the health of people in the United States. Additionally, the government is supporting the market for air quality equipment, which is measuring and regulating polluted air and growing public-private collaboration for air quality monitoring in the region.

Competitive Landscape

The medical active air sampling system market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Sartorius, MBV AG, Particle Measuring Systems, LightHouse, bioMerieux, Sarstedt, Orum International, Emtek, Bertin Technologies, Climet Instruments, and among others. The major players are adopting several growth strategies such as new product launches, acquisitions, and collaborations, which are contributing to the growth of the medical active air sampling system market globally.

For instance,

• In October 2020, MBV AG introduced the MAS-100 Regulus digital anemometer for calibration of MAS-100 Microbial Air Samplers.

• In May 2021, Particle Measuring Systems (PMS) launched the Lasair Pro Airborne Particle Counter. This meets the riding demands for cleanroom environmental monitoring.

MBV AG

Overview:

MBV AG is based in Stäfa, Zurich. It produces high-quality and innovative air samplers to measure microbial air contamination. They launched the successful series of MAS-100 in 1996.

Device type Portfolio:

MICROBIAL AIR SAMPLER MAS-100 NT: The MAS-100 NT sampler is an advanced version of the portable MAS-100 instruments. It is used for microbial monitoring of air. It is made up of a high-precision mass flow sensor, which provides the highest safety and is therefore mainly used in sensitive areas and cleanrooms.

The global medical active air sampling system market report would provide access to approximately 53 market data tables, 43 figures, and in the range of 200 (approximate) pages.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.